Administration of the MDR1 PGP antagonist elacridar induces neuroendocrine and behavioural changes in mice selectively bred for extremes in stress reactivity / Heinzmann, J. M., Uhr, M., Touma, C.. Endocrine regulations Vol. 45, no. 2 (2011), s. [129]